Skip to content
The Policy VaultThe Policy Vault

pyrimethamine — CareFirst (Caremark)

Congenital toxoplasmosis (pediatric patient)

Initial criteria

  • The requested drug is being prescribed for the treatment of congenital toxoplasmosis in a pediatric patient.

Approval duration

12 months